Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1988-08-29
1992-02-18
Moezie, F. T.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 2, 514 21, 530324, 530350, A61K 3702, A61K 3736, C07K 1300
Patent
active
050894730
ABSTRACT:
Variant forms of mammalian somatotropins, particularly bovine and porcine somatotropin, in which the asparagine located between positions 95-101 has been replaced by glutamine exhibit enhanced stability at high pH and at elevated temperatures while retaining bioactivity equivalent to the corresponding unmutated somatotropins, and are useful in the treatment of animals to enhance growth and/or milk production.
REFERENCES:
Proc. Nat'l. Acad. Sci., U.S.A., 84:6434-37, (1987), S. S. Abdel-Megui et al., "Three-Dimensional Structure of a Genetically Engineered Variant of Porcine Growth Hormone".
Krivi Gwen G.
Schlittler Michael R.
Violand Bernard N.
Clayman Carol H.
Eberhardt Wayne R.
Moezie F. T.
Monsanto Company
Swaney Larry R.
LandOfFree
Somatotropin variants and their use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Somatotropin variants and their use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Somatotropin variants and their use will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1823601